Clinical trial
rhuFVIIa in Post-partum Hemorrhage
NCT00370877 · Centre Hospitalier Universitaire de Nīmes, Other · Completed
Key facts
| NCT number | NCT00370877 |
|---|---|
| Title | rhuFVIIa in Post-partum Hemorrhage |
| Official title | Recombinant Human Activated Factor VII as Salvage Therapy in Women With Severe Postpartum Hemorrhage |
| Lead sponsor | Centre Hospitalier Universitaire de Nīmes, Other |
| Collaborators | University Hospital, Lille Assistance Publique - Hôpitaux de Paris University Hospital, Montpellier University Hospital, Geneva Centre Hospitalier Universitaire de Nice |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Postpartum Hemorrhage |
| Intervention type | Drug, Procedure |
| Interventions | rFVIIa, Standard Care |
| Enrollment | 84 |
| Start date | Apr 1, 2007 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Sep 1, 2006 |
| Last update posted | Mar 27, 2015 |
| Countries | France, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: